This week's View explores the benefit of uninterrupted direct oral anticoagulant versus uninterrupted vitamin K antagonist use for patients undergoing catheter ablation for nonvalvular atrial fibrillation; which therapy, anticoagulation or antiplatelet, is better for preventing stroke recurrence in patients with patent foramen ovale and a history of stroke or transient ischemic attack; and whether a post-procedural increase in creatine kinase-myocardial band or cardiac troponin is associated with high risk of death at 1 year in patients with stable angina undergoing percutaneous coronary intervention.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Angina, Stable, Anticoagulants, Arrhythmias, Cardiac, Biomarkers, Atrial Fibrillation, Catheter Ablation, Cerebral Infarction, Comorbidity, Creatine Kinase, MB Form, Drug-Eluting Stents, Foramen Ovale, Patent, Heart Defects, Congenital, Hemorrhage, Heparin, Ischemic Attack, Transient, Myocardium, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Risk, Secondary Prevention, Stroke, Thromboembolism, Troponin, Vascular Diseases, Vitamin K, Warfarin

< Back to Listings